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Background Before 2003, little was known about the scale of China’s HIV/AIDS
epidemic. In 2003, the Chinese government produced national
estimates with support from the Joint United Nations Programme
on HIV/AIDS, the World Health Organization and the United States
Centers for Disease Control and Prevention. Subsequent national
estimation exercises were carried out in 2005, 2007 and 2009. We
describe these estimation processes and present the results of
China’s HIV/AIDS estimation exercises from 2003 to 2009.
Methods The Workbook Method was used to generate national HIV/AIDS
estimates. Data from the provincial level were used in 2003, data
from the prefecture level were used in 2005 and data from the
county level were used in 2007 and 2009. Data at the lowest level of
aggregation were used to estimate risk group population size and HIV
prevalence. Data from lower levels were combined into national
estimates.
Results At the end of 2003, 2005, 2007 and 2009, there were an estimated
0.84, 0.65, 0.70 and 0.74 million people living with HIV/AIDS in
China, respectively, with an overall HIV prevalence of 0.05–0.06%.
The number of new HIV infections decreased from 70000 in 2005,
to 50000 in 2007, to 48000 in 2009. Data quality improvements
have increased the precision of China’s HIV estimates.
Conclusion Repeated estimates have improved understanding of the HIV/AIDS
epidemic in China. HIV estimates are a valuable tool for guiding
national AIDS policies evaluating HIV prevention and control
programmes.
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Introduction
How serious is China’s HIV epidemic? This question
has generated significant speculation and debate over
the past decade. In the 1990s, when HIV began to
spread quickly throughout China, little was known
about the epidemic. The few data that were available
suggested alarming increases in HIV prevalence
among drug users (DUs)
1,2 and plasma donors.
3
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ii21In 2002, the United Nations Theme Group on HIV/
AIDS in China issued a controversial report citing
an estimated 1 million people living with HIV/AIDS
(PLWHA) in China in 2001, with a projected 10 mil-
lion infections by 2010 if countermeasures were not
taken.
4 Official sources at the time estimated that
the number of HIV cases had risen from 300000 in
1997 to 1 million in 2002.
5 China’s HIV epidemic
appeared to be escalating out of control, but without
good data, it was hard to gauge the true scope of the
epidemic.
Beginning in 2003, the Chinese government began
conducting systematic, biennial HIV/AIDS estimation
exercises to assess the HIV epidemic at the national
level. Working together with the Joint United Nations
Programme on HIV/AIDS (UNAIDS), the World
Health Organization (WHO) and the United States
Centers for Disease Control and Prevention (US
CDC), the Chinese government estimated that there
were 840000 PLWHA by the end of 2003, among
whom 80000 had developed AIDS.
5 This estimation
exercise revealed a number of data gaps: limited or
absent data at the county level, a small number of
epidemiological studies of HIV and sexually trans-
mitted infections (STIs) and limited surveillance
data from sites in high-prevalence areas.
6 Because of
the limited data available in 2003, estimates were
prepared at the provincial level (the word ‘province’
in this article refers to all provinces, autonomous
regions and municipalities including the Xingjiang
Production and Construction Corps), making the
precision. Since 2003, the Chinese government has
taken measures to improve data availability and
data quality. First, the government has expanded
the HIV sentinel surveillance system from 148 sites
in 2003 to 1029 sites in 2009.
6,7 This has expanded
geographic coverage and coverage of specific risk
groups. For example, 25 surveillance sites assessed
HIV trends among men who have sex with men
(MSM) in 2009, compared with just 1 site in 2003
and 2005. Secondly, the government has established
and expanded the HIV behavioural surveillance
system, which provides essential data on risk behav-
iours in various subpopulations. Thirdly, the govern-
ment has strengthened the HIV/AIDS case reporting
system, including improving laboratory services to
support HIV screening and confirmation testing.
Finally, the government has conducted a number of
special studies, including large-scale HIV screening
among former plasma donors in central China.
8
As more and more data have become available,
China’s HIV/AIDS estimates have become increas-
ingly reliable. In 2005, 2007 and 2009, China con-
ducted three more rounds of HIV/AIDS estimation
exercises using the Workbook Method recommended
by the WHO and the UNAIDS.
9–13 Here, we describe
these estimation processes, review the results of
these estimation exercises and outline the challenges
ahead.
Methods
The estimation process
China’s national HIV estimates have been generated
through consultative processes involving key stake-
holders. In 2005, the National HIV Epidemic
Estimation Working Group was formed to support
national HIV/AIDS estimation processes.
10 The work-
ing group includes domestic experts from the Ministry
of Health (MOH) Expert Advisory Committee on HIV/
AIDS; the National Center of AIDS/STD Control and
Prevention (NCAIDS) within the Chinese Center for
Disease Control and Prevention (China CDC); Peking
University; Tsinghua University; Fudan University;
Peking Union Medical College; Renmin University;
and other universities and organizations. The group
also includes international experts from the WHO,
the UNAIDS, the US CDC and other organizations.
Over the course of the estimation processes in 2005,
2007 and 2009,
9–11 the group met to review estima-
tion guidelines, to train key provincial level staff, to
provide technical support and to oversee estimation
analyses.
National guidelines have been established to guide
the estimation process. In 2005, NCAIDS staff drafted
guidelines to ensure comparability of data across
geographical areas, along with an implementation
manual.
13 The guidelines and implementation man-
ual were pilot tested in one province before being
applied nationwide. In 2007, the guidelines and
implementation manual were updated to reflect param-
eter adjustments, standardization of terms and defin-
itions and rules for borrowing estimates across
geographical areas in places where data were not
available.
14,15
Using national guidelines, provinces prepared draft
HIV/AIDS estimates. In 2005, provincial estimates
were based on prefecture-level Workbook spreadsheets.
In 2007 and 2009, when more data were available,
county-level Workbook spreadsheets were prepared.
In 2005, 2007 and 2009, province-level Workbook
spreadsheets were reviewed by regional working
groups formed from the National HIV Epidemic
Estimation Working Group. After these were reviewed,
each provincial health bureau (or health depart-
ment) and CDC jointly finalized the provincial esti-
mates. NCAIDS staff then prepared national estimates
with support from the National HIV Epidemic
Estimation Working Group. The national estimates in
2005, 2007 and 2009 were reviewed by representatives
from the UNAIDS and the WHO Geneva headquarters,
and suggested adjustments were incorporated into the
final national estimates.
Prior to each estimation exercise, staff at each level
were trained on how to produce HIV estimates using
the Workbook Method. At the beginning of the
process, senior technical staff from the national and
provincial levels attended a training workshop orga-
nized by the UNAIDS and the WHO in Bangkok,
Thailand. After senior technical staff received the
ii22 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYtraining, a national training workshop was organized
with consultants hired by the UNAIDS, and provincial
training workshops were organized in each province.
By 2009, nearly 75% of the staff workers had already
participated in at least one of the previous estimation
exercises.
Data sources
Demographic data
Demographic data came primarily from publicly avail-
able census data in the previous 2 years, i.e. 2001, 2003,
2005 and 2007, from the National Bureauof Statistics of
China, and adjusted by the number of annual reported
births and deaths from national health statistics.
HIV prevalence data
HIV prevalence data came primarily from China’s
HIV sentinel surveillance system. When possible, data
from the previous 12 months were used. When recent
data were not available, adjustments were made to
previous data as considered necessary by local CDC
officials.
To generate HIV estimates for high-risk populations,
sentinel surveillance data, behavioural surveillance
survey (BSS) data, special epidemiological survey
data, public security bureau (PSB) registration data
and data from the published literature were used.
Between 2003 and 2009, the number of HIV sentinel
surveillance sites has grown (Table 1). Coverage of
specific populations, such as MSM, has greatly
improved (from 1 site in 2003 and 2005 to 25 sites
in 2009).
To generate HIV estimates for low-risk populations
(e.g. the regular sex partners of high-risk individuals),
different data sources were used depending on
whether an area qualified as a low or high HIV preva-
lence area (<1 vs 41% antenatal HIV prevalence, re-
spectively). The majority of areas fell into the low-
prevalence category. In these places, HIV serodiscor-
dant couple survey data from Xinjiang and Henan
provinces were used as a proxy for HIV prevalence
among the regular sex partners of high-risk individ-
uals. For high-prevalence areas, antenatal clinic data
were used as a proxy for HIV prevalence among the
regular sex partners of high-risk individuals.
Population size estimates
High and low estimates were made for the sizes of
high-risk populations. As recommended by interna-
tional guidelines, most population size estimates
used indirect multiplier methods.
16 To estimate the
population size of regular partners of high-risk indi-
viduals, data from two sources were collected: (i) pro-
portion of high-risk population such as MSM that
engage in heterosexual relationships; and (ii) propor-
tion of HIV-infected plasma blood donors who were
married.
Data for population size estimates came primarily
from field investigations, behavioural surveillance
and registration records from various government
agencies, such as the Public Security Bureau.
Hospital testing and case reports were also taken
into consideration. Data sources and population size
estimation methods for the 2005 and 2007 estimation
exercises have been described elsewhere.
14,17
Missing data
Missing HIV prevalence and population size data for
specific areas were imputed using data from areas
with similar geographic and socio-economic charac-
teristics. Decisions on how to impute data were
made in consultation with experts from the National
HIV Epidemic Estimation Working Group and local
health officials.
Data quality
In 2007, at the suggestion of the UNAIDS, NCAIDS
staff conducted systematic evaluations of data quality,
verifying results against other estimation methods.
14
Data quality were also assessed in 2009.
11
A system for scoring data quality was established in
the 2007 National HIV/AIDS Estimation Technical
Guidelines.
15 In rating the quality of HIV prevalence
data, points were given for the following categories:
sample quality and sample size (10 points); sampling
method (4 points); all subjects belongs to designated
specific sentinel group (1 point). A maximum of
17 points was possible; over 13 points was ‘excellent’,
7–12 points was ‘good’ and 0–6 was ‘acceptable’ . If
data were not readily available, data from another
province or population of a similar HIV/AIDS epi-
demic situation was used. In these cases, a score of
3 points was given. In rating the quality of population
size estimates, points were given as follows based on
the data source used for the estimates: population-
based survey data (6 points); population statistics
plus select survey data (5 points); population statistics
plus expert estimates (4 points); adjusted Public
Security Bureau registration data for community-
based injecting drug users (IDUs; 4 points); similar
Table 1 Number of national HIV sentinel surveillance sites
that contributed data to China’s national HIV estimates,
2003–09
Population 2003 2005 2007 2009
Female SWs 32 49 229 367
DUs/IDUs 36 62 229 243
MSM 1 1 11 25
STD outpatients 58 90 267 231
Pregnant women 13 26 75 66
Truck drivers 8 20 43 46
Other
a – – 75 51
Total 148 248 929 1029
aOther includes students and tuberculosis patients.
SWs: sex workers, STD: sexually transmitted disease.
HIV/AIDS ESTIMATION IN CHINA ii23population statistics and information (4 points); other
area data (3 points); unadjusted Public Security
Bureau registration data of IDUs (2 points); and
expert estimation (1 point). A maximum of 6 points
was possible. A score of at least 5 points was ‘excel-
lent’, 3–4 points was ‘good’ and 1–2 points was
‘acceptable’.
Estimation methods
Estimates of HIV prevalence were generated using
the Workbook Method recommended by the UNAIDS
and the WHO for countries with low level or concen-
trated epidemics. This method has been described in
detail elsewhere.
13 Population size estimates for various
subpopulations are entered into Workbook spread-
sheets. HIV prevalence data are entered and applied
to each subpopulation to generate an estimated
number of people living with HIV for each subpopula-
tion. High and low estimates for both population
size and HIV prevalence are used to reflect uncertainty
around estimates, and this gives rise to a range around
point estimates.
Adaptations to the Workbook Method were made to
account for the special characteristics of China’s HIV
epidemic. The adaptations made in 2005 and 2007
have been described elsewhere.
14,17
National-level estimates of HIV prevalence were
generated based on provincial Workbook spread-
sheets. Provincial data were aggregated to produce
national estimates.
In 2005, 2007 and 2009, estimates of new HIV infec-
tions and HIV-related deaths were generated using
the Estimation and Projection Package (EPP)
18 and
Spectrum
19 software packages developed by the
UNAIDS and the WHO. EPP generates a national HIV
prevalence curve based on prevalence curves from lower
levels of geographical aggregation (e.g. county,
prefecture or province curves) and different subpopula-
tions. EPP output is entered into Spectrum to calculate
the annual number of new HIV infections and deaths
since the start of the epidemic. Details of the application
of EPP and Spectrum during the 2005 and 2007 estima-
tion exercises have been described elsewhere.
14,17
Results
Estimated HIV/AIDS cases
Key findings from China’s 2003, 2005, 2007 and 2009
HIV/AIDS estimation exercises are presented in
Table 2. The estimated number of PLWHA dropped
from 840000 in 2003 to 650000 in 2005, then rose
to 700000 in 2007 and 740000 in 2009. The estimated
number of AIDS cases fell from 80000 in 2003 to
75000 in 2005, then rose to 85000 in 2007 and
105000 in 2009. The estimated number of new HIV
infections fell from 70000 in 2005 to 50000 in 2007
and 48000 in 2009.
The estimated number of PLWHA by mode of trans-
mission is presented in Table 3. In 2003, estimates
were not stratified by mode of transmission.
Between 2005 and 2009, the proportion of estimated
cases associated with sexual transmission increased
and the proportion of estimated cases associated
with injecting drug use transmission decreased.
The estimated number of new HIV infections by
mode of transmission is presented in Table 4.
Dramatic increases in HIV transmission among
MSM have been observed in recent years.
Data quality assessments
In 2007 and 2009, we assessed the quality of HIV
prevalence and population size data. A comparison
of the quality of population size data used for the
Table 2 China’s national HIV/AIDS estimates, 2003–09
Estimated number of people
2003 2005 2007 2009
PLWHA
Point estimate 840000 650000 700000 740000
Range 650000–1200000 540000–760000 550000–850000 560000–920000
AIDS cases
Point estimate 80000 75000 85000 105000
Range 65000–85000 80000–90000 97000–112000
AIDS deaths
Point estimate 25000 20000 26000
Range 20000–30000 15000–25000 22000–30000
New HIV infections
Point estimate 70000 50000 48000
Range 60000–80000 40000–60000 41000–55000
ii24 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY2007 and 2009 estimates is presented in Figure 1A.
Subpopulations included DUs (DUs and IDUs), sex
workers (SWs), clients of SWs, urban MSM, rural
MSM, former plasma donors and low-risk popula-
tions. From 2007 to 2009, the proportion of data clas-
sified as ‘excellent’ increased for all subpopulations.
The proportion of data classified as ‘excellent’ or
‘good’ also increased for all subpopulations, with the
exception of a slight decrease for DUs/IDUs (from
98.9% in 2007 to 98.4% in 2009).
A comparison of the quality of HIV prevalence data
used for the 2007 and 2009 estimates is presented in
Figure 1B. The quality of data sources categorized as
‘excellent’ or ‘good’ increased for all subpopulations.
The proportion of data sources categorized as ‘excel-
lent’ increased from 2007 to 2009 for all subpopula-
tions except for low-risk populations (decreased from
7.1% in 2007 to 6.0% in 2009).
Discussion
Multiple rounds of national estimation exercises have
improved the accuracy of China’s HIV/AIDS estimates.
Early estimates were based on limited data from
high-prevalence areas and high-risk populations, and
were hence higher than subsequent estimates based
on more complete data from an expanded HIV sur-
veillance system. Between 2003 and 2005, for ex-
ample, national estimates of the number of PLWHA
fell from 840000 in 2003 to 650000 in 2005. Two
factors were primarily responsible for this drop.
10
First, estimates in 2003 were most likely overesti-
mated the epidemic but estimates in 2005 reflected
the epidemic better since a wider range of data had
became available, including data from a 2004 mass
HIV screening of former plasma donors in central
China and data from a greatly expanded HIV sentinel
surveillance system. Secondly, more precise geograph-
ical units were used in preparing the estimates. In
2003, estimates were done at the provincial level,
and the estimates were done at the prefecture level
in 2005.
Between 2005 and 2009, HIV data availability
continued to improve. First, the number of national
and provincial HIV sentinel surveillance sites contri-
buting data to China’s national HIV estimates
increased from 929 sites in 2007 to 1029 sites in
2009. The largest increases were in the number of
sites contributing data for female SWs (2007: 229
sites; 2009: 367 sites) and MSM (2007: 11 sites;
2009: 25 sites). This increase in number of sites
reflects the growing importance of sexual transmis-
sion, which in 2005 overtook injecting drug use as
the leading mode of HIV transmission. Secondly,
more data are now available from expanded surveil-
lance and special surveys. For example, three rounds
of national surveys of MSM in 61 cities have provided
more accurate assessments of HIV prevalence and risk
behaviours within MSM communities around the
country.
The quality of HIV data has also continued to im-
prove. From 2007 to 2009, there was marked improve-
ment in the proportion of HIV prevalence data
classified as ‘excellent’ or ‘good’ across all popula-
tions. The quality of data used for population size
estimates has also improved over time.
The increase of number of PLWHA may be influ-
enced by two factors. First, with rapid scale-up of
the national free antiretroviral treatment programme,
PLWHA live longer.
20 Secondly, even if a reduction of
new HIV infections were observed, there are still a
considerable number of people infected with HIV
each year.
The rapid increase in HIV prevalence among MSM
in recent years is a major cause for concern. Among
both urban and rural MSM, estimated HIV prevalence
has increased during each round of estimation since
2005. In 2009, MSM accounted for nearly one-third of
new HIV infections in China.
For future HIV/AIDS estimation exercises, improve-
ments still need to be made. There are still many
data gaps to be filled. For example, further
Table 3 Estimated number of PLWHA in China, by
transmission mode: 2003–09
2003
(840000)
2005
(650000)
(%)
2007
(700000)
(%)
2009
(740000)
(%)
Sexual contact NA 43.6 51.6 59.0
Heterosexual 36.3 40.6 44.3
Homosexual 7.3 11 14.7
Injecting
drug use
NA 44.3 38.1 32.2
Mother-to-child
transmission
NA 1.4 1.0 1.0
Plasma/blood NA 10.7 9.3 7.8
Total 100 100 100
NA: not available.
Table 4 Estimated number of new HIV infections in China,
by transmission mode: 2003–09
2003
(NA)
2005
(70000)
(%)
2007
(50000)
(%)
2009
(48000)
(%)
Sexual contact NA 49.8 56.9 74.7
Heterosexual NA 44.7 42.2
Homosexual NA 12.2 32.5
Injecting drug use NA 48.6 42.0 24.3
Mother-to-child
transmission
NA 1.6 1.0 1.0
Total 100 100 100
NA: not available.
HIV/AIDS ESTIMATION IN CHINA ii25attention must be paid to HIV among the male clients
of SWs and rural MSM. HIV surveillance sites need
to be further expanded to cover smaller and
medium-sized cities. Methodological limitations
must also be addressed. The Workbook Method
provides a good starting point for generating national
HIV/AIDS estimates, but it may not accurately reflect
the large regional differences in China’s HIV/AIDS
epidemic. The Workbook Method also currently does
not have the ability to generate estimates for a
number of populations, including MSM450-year-old,
migrant wives, those infected via blood and or/blood
products, mother-to-child transmission, sailors and
foreigners.
Conclusion
Repeated rounds of national HIV/AIDS estimate exer-
cises in 2003, 2005, 2007 and 2009 have generated
data that more accurately reflect China’s heteroge-
neous epidemic. Improvements in data quality
Figure 1 Data quality evaluation for data being used in estimation of HIV/AIDS in China in 2007 and 2009. (A) Population
size data and (B) HIV prevalence data. FPD: Former plasma donors
ii26 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYand data availability have improved the precision of
HIV/AIDS estimates, providing information that is
critical to public health priority setting and
policymaking.
In the coming years, the government should
continue to improve the quality and amount of data
available for HIV/AIDS estimation exercises. Accurate
estimates based on high-quality data will help the
Chinese government, international organizations
and civil society better target HIV testing, prevention,
treatment and care programmes to curtail the Chinese
HIV/AIDS epidemic.
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